Suppr超能文献

咪唑啉和胍衍生物对大鼠门静脉中左旋克罗卡林的拮抗作用:延迟整流器的参与

Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.

作者信息

Ibbotson T, Edwards G, Weston A H

机构信息

Department of Physiological Sciences, University of Manchester.

出版信息

Br J Pharmacol. 1993 Dec;110(4):1556-64. doi: 10.1111/j.1476-5381.1993.tb14001.x.

Abstract
  1. In rat whole portal veins, guanabenz (100 nM to 10 microM) and antazoline (100 nM to 100 microM) each increased the amplitude, frequency and duration of spontaneous contractions. In addition, guanabenz (30 microM) and antazoline (30 microM) each antagonized the ability of levcromakalim (3 nM to 10 microM) to inhibit the spontaneous contractions of this tissue. 2. Whole-cell voltage-clamp recordings were made from freshly-isolated rat portal vein cells dispersed by a collagenase/pronase enzyme treatment. The ability of several agents (antazoline, cirazoline, clonidine, guanabenz and phentolamine, each containing an imidazoline or guanidine moiety), to modulate potassium (K) currents and to inhibit the actions of levcromakalim was investigated. 3. Antazoline, cirazoline, clonidine, guanabenz and phentolamine (each at a concentration of 30 microM) had little effect on control non-inactivating currents but inhibited the delayed-rectifier current, IK(V). 4. Levcromakalim (1 microM) induced a non-inactivating current, IK(ATP), and also inhibited the delayed rectifier current, IK(V). 5. Glibenclamide (1 microM) had no effect on control delayed rectifier or non-inactivating currents, but it inhibited the simultaneous induction of IK(ATP) and reduction of IK(V) produced by levcromakalim (1 microM). 6. Antazoline, cirazoline, clonidine and guanabenz (each at a concentration of 30 microM) prevented the induction of IK(ATP) by levcromakalim (1 microM). Phentolamine (30 microM) and clonidine (30 microM) each inhibited the IK(ATP) generated by levcromakalim (1 microM). 7. It is concluded that a variety of agents which possess either an imidazoline (antazoline, cirazoline, clonidine and phentolamine) or a guanidine (guanabenz) moiety within their structure inhibit the delayed rectifier current, IK(V). This action may thus be mediated via a so-called non-adrenoceptor imidazoline binding site. Furthermore, the ability of these ligands to inhibit IK(V) and to antagonize both the induction of IK(ATP) and the vasorelaxation produced by levcromakalim is consistent with the view that the channel (KATP) which underlies IK(ATP) is a voltage-insensitive state of the delayed rectifier K-channel (Kv).
摘要
  1. 在大鼠全门静脉中,胍那苄(100 nM至10 μM)和安他唑啉(100 nM至100 μM)均可增加自发收缩的幅度、频率和持续时间。此外,胍那苄(30 μM)和安他唑啉(30 μM)均可拮抗左卡尼汀(3 nM至10 μM)抑制该组织自发收缩的能力。2. 采用胶原酶/链霉蛋白酶处理分散的新鲜分离大鼠门静脉细胞进行全细胞膜片钳记录。研究了几种药物(安他唑啉、西拉唑啉、可乐定、胍那苄和酚妥拉明,均含有咪唑啉或胍基部分)调节钾(K)电流以及抑制左卡尼汀作用的能力。3. 安他唑啉、西拉唑啉、可乐定、胍那苄和酚妥拉明(均为30 μM浓度)对对照非失活电流影响很小,但抑制延迟整流电流IK(V)。4. 左卡尼汀(1 μM)诱导非失活电流IK(ATP),并抑制延迟整流电流IK(V)。5. 格列本脲(1 μM)对对照延迟整流或非失活电流无影响,但抑制左卡尼汀(1 μM)同时诱导的IK(ATP)和IK(V)的降低。6. 安他唑啉、西拉唑啉、可乐定和胍那苄(均为30 μM浓度)可阻止左卡尼汀(1 μM)诱导IK(ATP)。酚妥拉明(30 μM)和可乐定(30 μM)均可抑制左卡尼汀(1 μM)产生的IK(ATP)。7. 得出结论,多种在其结构中含有咪唑啉(安他唑啉、西拉唑啉、可乐定和酚妥拉明)或胍基(胍那苄)部分的药物抑制延迟整流电流IK(V)。因此,这种作用可能通过所谓的非肾上腺素能咪唑啉结合位点介导。此外,这些配体抑制IK(V)以及拮抗左卡尼汀诱导的IK(ATP)和血管舒张的能力与以下观点一致,即IK(ATP)所基于的通道(KATP)是延迟整流钾通道(Kv)的电压不敏感状态。

相似文献

1
咪唑啉和胍衍生物对大鼠门静脉中左旋克罗卡林的拮抗作用:延迟整流器的参与
Br J Pharmacol. 1993 Dec;110(4):1556-64. doi: 10.1111/j.1476-5381.1993.tb14001.x.
3
ATP耗竭对大鼠门静脉钾通道的调节作用:与左西孟旦(BRL 38227)作用的比较。
Br J Pharmacol. 1992 Dec;107(4):945-55. doi: 10.1111/j.1476-5381.1992.tb13390.x.
4
通过对大鼠门静脉胰岛素瘤细胞中延迟整流通道进行修饰来诱导格列本脲敏感的钾电流。
Br J Pharmacol. 1993 Dec;110(4):1280-1. doi: 10.1111/j.1476-5381.1993.tb13955.x.
5
利沃卡利姆在兔门静脉平滑肌细胞中诱发的单通道和全细胞钾电流。
Br J Pharmacol. 1993 Oct;110(2):583-90. doi: 10.1111/j.1476-5381.1993.tb13850.x.
6
BRL55834对大鼠门静脉和牛气管的作用:诱导格列本脲抵抗性ATP敏感性钾电流的证据。
Br J Pharmacol. 1995 Jul;115(6):1027-37. doi: 10.1111/j.1476-5381.1995.tb15914.x.
7
P1060和阿普卡林对大鼠门静脉全细胞电流的影响;格列本脲和酚妥拉明的抑制作用。
Br J Pharmacol. 1993 Apr;108(4):991-8. doi: 10.1111/j.1476-5381.1993.tb13496.x.
9
钾通道在西氯吲哚对大鼠门静脉作用中的参与情况。
Br J Pharmacol. 1992 May;106(1):17-24. doi: 10.1111/j.1476-5381.1992.tb14286.x.

引用本文的文献

1
从石珊瑚 Galaxea astreata 中克隆和鉴定钙调蛋白样蛋白 CaLP。
Cell Stress Chaperones. 2018 Nov;23(6):1329-1335. doi: 10.1007/s12192-018-0907-0. Epub 2018 Jun 7.
2
细胞色素P450抑制剂对大鼠门静脉钾电流和机械活性的影响。
Br J Pharmacol. 1996 Oct;119(4):691-701. doi: 10.1111/j.1476-5381.1996.tb15728.x.
3
抗心律失常药西苯唑啉对胰腺ATP敏感性钾通道的阻断作用及促胰岛素分泌作用
Br J Pharmacol. 1996 Apr;117(8):1749-55. doi: 10.1111/j.1476-5381.1996.tb15349.x.
5
钾通道开放剂的药理学
Cardiovasc Drugs Ther. 1995 Mar;9 Suppl 2:185-93. doi: 10.1007/BF00878465.
6
推测的大电导钙激活钾通道开放剂NS 1619对血管平滑肌离子通道的调节作用
Br J Pharmacol. 1994 Dec;113(4):1538-47. doi: 10.1111/j.1476-5381.1994.tb17171.x.

本文引用的文献

1
ATP敏感性钾通道的药理学
Annu Rev Pharmacol Toxicol. 1993;33:597-637. doi: 10.1146/annurev.pa.33.040193.003121.
2
P1060和阿普卡林对大鼠门静脉全细胞电流的影响;格列本脲和酚妥拉明的抑制作用。
Br J Pharmacol. 1993 Apr;108(4):991-8. doi: 10.1111/j.1476-5381.1993.tb13496.x.
4
用于从细胞和无细胞膜片进行高分辨率电流记录的改进膜片钳技术。
Pflugers Arch. 1981 Aug;391(2):85-100. doi: 10.1007/BF00656997.
6
酚妥拉明及结构相关化合物可选择性拮抗钾通道开放剂色满卡林的血管作用。
Br J Pharmacol. 1989 Jul;97(3):941-9. doi: 10.1111/j.1476-5381.1989.tb12035.x.
7
从兔门静脉分离的平滑肌细胞中,克罗卡林诱导的钾离子电导特性。
Br J Pharmacol. 1989 Nov;98(3):851-64. doi: 10.1111/j.1476-5381.1989.tb14614.x.
10
克罗卡林诱导的豚鼠离体气管舒张:格列本脲和酚妥拉明的拮抗作用。
Br J Pharmacol. 1989 Nov;98(3):865-74. doi: 10.1111/j.1476-5381.1989.tb14615.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验